Personal information

Emails & domains

Verified email domains

Other IDs

Scopus Author ID: 57203261315

Activities

Collapse all

Employment (4)

University of Central Florida: Orlando, FL, US

2016-08-05 to present | Research Assistant (Burnett School of Biomedical Sciences)
Employment
Source: Self-asserted source
Michael Shehat

Alexandria University Faculty of Pharmacy: Alexandria, EG

2014-12-15 to present | Assistant Lecturer (Microbiology and Immunology)
Employment
Source: Self-asserted source
Michael Shehat

University of Central Florida: Orlando, FL, US

2015-08-05 to 2016-08-05 | Teaching Assistant (Burnett School of Biomedical Sciences)
Employment
Source: Self-asserted source
Michael Shehat

Alexandria University Faculty of Pharmacy: Alexandria, EG

2011-10 to 2014-12-15 | Demonstrator (pharmaceutical microbiology department)
Employment
Source: Self-asserted source
Michael Shehat

Education and qualifications (3)

University of Central Florida: Orlando, Florida, US

2015-08-05 to 2020-05-02 | PhD in Biomedical Sciences (Burnett School of Biomedical Sciences)
Education
Source: Self-asserted source
Michael Shehat

Alexandria University Faculty of Pharmacy: Alexandria, EG

2011-10 to 2014-12-14 | Master Degree (Pharmaceutical Microbiology)
Education
Source: Self-asserted source
Michael Shehat

Alexandria University Faculty of Pharmacy: Alexandria, EG

2006-09 to 2011-06 | Bachelor of pharmaceutical sciences
Education
Source: Self-asserted source
Michael Shehat

Funding (1)

Investigation of anti-hepatitis C (HCV) antibodies in the serum of HCV-infected Egyptian patients at different stages of disease prognosis and treatment

Grant
Science and Technology Development Fund (Cairo, EG)
Source: Self-asserted source
Michael Shehat

Works (18)

Unveiling the structural aspects of novel azo-dyes with promising anti-virulence activity against MRSA: a deep dive into the spectroscopy via integrated experimental and computational approaches

RSC Advances
2025 | Journal article
DOI: 10.1039/d4ra06367h
EID:

2-s2.0-85215755741

Part of ISSN: 20462069
Contributors: Hegazy, A.M.; Shehat, M.G.; Abouelfetouh, A.; Teleb, M.; Khattab, S.N.; Haiba, N.S.
Source: Self-asserted source
Michael Shehat via Scopus - Elsevier

Lipopolysaccharide nanomedicine-based reversion of chemotherapy-induced metastatic potential of breast cancer via hampering tumoral TLR4/SIRT2 axis and IL6 secretion from tumor-associated macrophages

International Journal of Biological Macromolecules
2025-05 | Journal article
DOI: 10.1016/j.ijbiomac.2025.141396
Part of ISSN: 0141-8130
Contributors: Yosra S. Mahmoud; Islam A. Hassanin; Sally A. Sabra; Michael G. Shehat; Mohamed A. Abdel-Mohsen; Sherine N. Khattab; Ahmed A. Hussein
Source: Self-asserted source
Michael Shehat

Synthesis of Marine-Inspired Multifaceted DNA Damaging Spirooxindoles Combating NSCLC and Associated Bacterial Infection

ACS Medicinal Chemistry Letters
2025-04-18 | Journal article
DOI: 10.1021/acsmedchemlett.5c00014
Part of ISSN: 1948-5875
Part of ISSN: 1948-5875
Contributors: Mohammad Shahidul Islam; Prof. Dr. Assem Barakat; Abdul Majeed Abdullah Alayyaf; Matti Haukka; Ved Prakash Verma; Marwa M. Abu-Serie; Amira El-Yazbi; Michael G. Shehat; Mustafa Alseqely; Mohamed Teleb
Source: Self-asserted source
Michael Shehat

Promising antifungal properties of the orally active autophagy inhibitor SBP-7455 against fluconazole-resistant Candida clinical isolates

Letters in Applied Microbiology
2025-04-11 | Journal article
DOI: 10.1093/lambio/ovaf055
Contributors: Mark A Rassan; Radwa Ewaisha; Hend Zeitoun; Michael G Shehat
Source: check_circle
Crossref

Challenging the Biginelli scaffold to surpass the first line antitubercular drugs: Mycobacterium tuberculosis thymidine monophosphate kinase (TMPK mt ) inhibition activity and molecular modelling studies

Journal of Enzyme Inhibition and Medicinal Chemistry
2024-12-31 | Journal article
DOI: 10.1080/14756366.2024.2386668
Contributors: Mai S. El-Shoukrofy; Amal Atta; Salwa Fahmy; Dharmarajan Sriram; Michael G. Shehat; Ibrahim M. Labouta; Mona A. Mahran
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Chemosensitization of non-small cell lung cancer to sorafenib via non-hydroxamate s-triazinedione-based MMP-9/10 inhibitors

Bioorganic Chemistry
2024-01 | Journal article
DOI: 10.1016/j.bioorg.2024.107155
Part of ISSN: 0045-2068
Contributors: Hosam H. Khalil; Mohamed M. El-Sheshtawy; Sherine N. Khattab; Marwa M. Abu-Serie; Michael G. Shehat; Mohamed Teleb; Nesreen S. Haiba
Source: Self-asserted source
Michael Shehat
grade
Preferred source (of 2)‎

Atorvastatin liposomes in a 3D-printed polymer film: a repurposing approach for local treatment of oral candidiasis

Drug Delivery and Translational Research
2023 | Journal article
DOI: 10.1007/s13346-023-01353-4
EID:

2-s2.0-85159296327

Part of ISSN: 21903948 2190393X
Contributors: Nour, E.M.; El-Habashy, S.E.; Shehat, M.G.; Essawy, M.M.; El-Moslemany, R.M.; Khalafallah, N.M.
Source: Self-asserted source
Michael Shehat via Scopus - Elsevier
grade
Preferred source (of 2)‎

Borrelia burgdorferi-mediated induction of miR146a-5p fine tunes the inflammatory response in human dermal fibroblasts

PLoS ONE
2023 | Journal article
DOI: 10.1371/journal.pone.0286959
EID:

2-s2.0-85163363797

Part of ISSN: 19326203
Contributors: Victoria, B.; Noureddine, S.A.; Shehat, M.G.; Jewett, T.J.; Jewett, M.W.
Source: Self-asserted source
Michael Shehat via Scopus - Elsevier
grade
Preferred source (of 2)‎

Dietary fat differentially modulates the response of bone marrow-derived macrophages to TLR4 and NOD2 agonists

Innate Immunity
2023 | Journal article
DOI: 10.1177/17534259231193926
EID:

2-s2.0-85167399025

Part of ISSN: 17534267 17534259
Contributors: Shehat, M.G.; Miller, M.H.; Calder, A.N.; Gilbertson, T.A.; Tigno-Aranjuez, J.T.
Source: Self-asserted source
Michael Shehat via Scopus - Elsevier
grade
Preferred source (of 2)‎

Lactoferrin decorated bilosomes for the oral delivery of quercetin in type 2 diabetes: In vitro and in vivo appraisal

International Journal of Pharmaceutics
2023 | Journal article
DOI: 10.1016/j.ijpharm.2023.123551
EID:

2-s2.0-85175021755

Part of ISSN: 18733476 03785173
Contributors: Soliman, M.O.; El-Kamel, A.H.; Shehat, M.G.; Bakr, B.A.; El-Moslemany, R.M.
Source: Self-asserted source
Michael Shehat via Scopus - Elsevier
grade
Preferred source (of 2)‎

The Chlamydia trachomatis Tarp effector targets the Hippo pathway

Biochemical and Biophysical Research Communications
2021-07 | Journal article
DOI: 10.1016/j.bbrc.2021.05.057
Contributors: Michael G. Shehat; George F. Aranjuez; Jongeon Kim; Travis J. Jewett
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Immune Modulation of Allergic Asthma by Early Pharmacological Inhibition of RIP2

ImmunoHorizons
2020 | Journal article
DOI: 10.4049/immunohorizons.2000073
EID:

2-s2.0-85129542842

Part of ISSN: 25737732
Contributors: Miller, M.H.; Shehat, M.G.; Tigno-Aranjuez, J.T.
Source: Self-asserted source
Michael Shehat via Scopus - Elsevier

Immune Modulation of Allergic Asthma by Early Pharmacological Inhibition of RIP2

2020-06-30 | Preprint
DOI: 10.1101/2020.06.29.178665
Contributors: Madelyn H. Miller; Michael G. Shehat; Justine T. Tigno-Aranjuez
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

RIP2 promotes FcγR-mediated reactive oxygen species production

Journal of Biological Chemistry
2019-06-28 | Journal article
DOI: 10.1074/jbc.ra118.007218
Part of ISSN: 0021-9258
Part of ISSN: 1083-351X
Source: Self-asserted source
Michael Shehat
grade
Preferred source (of 2)‎

Flow Cytometric Measurement Of ROS Production In Macrophages In Response To FcγR Cross-linking

Journal of Visualized Experiments
2019-03-07 | Journal article
DOI: 10.3791/59167
Part of ISSN: 1940-087X
Source: Self-asserted source
Michael Shehat
grade
Preferred source (of 2)‎

Frontline Science: RIP2 promotes house dust mite-induced allergic airway inflammation

Journal of Leukocyte Biology
2018-09 | Journal article
DOI: 10.1002/jlb.4hi0118-017rr
Part of ISSN: 0741-5400
Source: Self-asserted source
Michael Shehat
grade
Preferred source (of 2)‎

Recombinant expression of the alternate reading frame protein (ARFP) of hepatitis C virus genotype 4a (HCV-4a) and detection of ARFP and anti-ARFP antibodies in HCV-infected patients.

2015-08 | Journal article
DOI: 10.1007/s00705-015-2465-4
PMID: 26036563
Contributors: Shehat MG; Bahey-El-Din M; Kassem MA; Farghaly FA; Abdul-Rahman MH; Fanaki NH
Source: Self-asserted source
Michael Shehat via Europe PubMed Central
grade
Preferred source (of 2)‎

Comparative study on diagnostic kits for anti-Hepatitis C antibodies tested in infected Egyptian patients

Conference poster
Source: Self-asserted source
Michael Shehat
How many people are using ORCID?